2-120989857-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001374353.1(GLI2):​c.3892C>T​(p.Pro1298Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0242 in 1,612,970 control chromosomes in the GnomAD database, including 588 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 35 hom., cov: 33)
Exomes 𝑓: 0.025 ( 553 hom. )

Consequence

GLI2
NM_001374353.1 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0310

Publications

6 publications found
Variant links:
Genes affected
GLI2 (HGNC:4318): (GLI family zinc finger 2) This gene encodes a protein which belongs to the C2H2-type zinc finger protein subclass of the Gli family. Members of this subclass are characterized as transcription factors which bind DNA through zinc finger motifs. These motifs contain conserved H-C links. Gli family zinc finger proteins are mediators of Sonic hedgehog (Shh) signaling and they are implicated as potent oncogenes in the embryonal carcinoma cell. The protein encoded by this gene localizes to the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. The encoded protein is associated with several phenotypes- Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI2 Gene-Disease associations (from GenCC):
  • holoprosencephaly 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, Ambry Genetics
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033062696).
BP6
Variant 2-120989857-C-T is Benign according to our data. Variant chr2-120989857-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0168 (2562/152358) while in subpopulation NFE AF = 0.0275 (1870/68018). AF 95% confidence interval is 0.0265. There are 35 homozygotes in GnomAd4. There are 1176 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 35 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI2NM_001374353.1 linkc.3892C>T p.Pro1298Ser missense_variant Exon 14 of 14 ENST00000361492.9 NP_001361282.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI2ENST00000361492.9 linkc.3892C>T p.Pro1298Ser missense_variant Exon 14 of 14 1 NM_001374353.1 ENSP00000354586.5 A0A7I2PJA1

Frequencies

GnomAD3 genomes
AF:
0.0168
AC:
2563
AN:
152240
Hom.:
35
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00453
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0165
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.000961
Gnomad SAS
AF:
0.0195
Gnomad FIN
AF:
0.00725
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0275
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.0163
AC:
4054
AN:
248274
AF XY:
0.0168
show subpopulations
Gnomad AFR exome
AF:
0.00386
Gnomad AMR exome
AF:
0.0110
Gnomad ASJ exome
AF:
0.00812
Gnomad EAS exome
AF:
0.000110
Gnomad FIN exome
AF:
0.00715
Gnomad NFE exome
AF:
0.0252
Gnomad OTH exome
AF:
0.0159
GnomAD4 exome
AF:
0.0249
AC:
36430
AN:
1460612
Hom.:
553
Cov.:
34
AF XY:
0.0246
AC XY:
17889
AN XY:
726606
show subpopulations
African (AFR)
AF:
0.00281
AC:
94
AN:
33478
American (AMR)
AF:
0.0107
AC:
479
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00896
AC:
234
AN:
26124
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39694
South Asian (SAS)
AF:
0.0159
AC:
1372
AN:
86240
European-Finnish (FIN)
AF:
0.00811
AC:
425
AN:
52412
Middle Eastern (MID)
AF:
0.0142
AC:
82
AN:
5766
European-Non Finnish (NFE)
AF:
0.0291
AC:
32387
AN:
1111828
Other (OTH)
AF:
0.0224
AC:
1351
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
2026
4051
6077
8102
10128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1242
2484
3726
4968
6210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0168
AC:
2562
AN:
152358
Hom.:
35
Cov.:
33
AF XY:
0.0158
AC XY:
1176
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00452
AC:
188
AN:
41594
American (AMR)
AF:
0.0165
AC:
253
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.000963
AC:
5
AN:
5190
South Asian (SAS)
AF:
0.0195
AC:
94
AN:
4824
European-Finnish (FIN)
AF:
0.00725
AC:
77
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0275
AC:
1870
AN:
68018
Other (OTH)
AF:
0.0218
AC:
46
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
141
281
422
562
703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0230
Hom.:
109
Bravo
AF:
0.0161
TwinsUK
AF:
0.0200
AC:
74
ALSPAC
AF:
0.0246
AC:
95
ESP6500AA
AF:
0.00341
AC:
15
ESP6500EA
AF:
0.0267
AC:
230
ExAC
AF:
0.0162
AC:
1971
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0262
EpiControl
AF:
0.0251

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 01, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19223936, 24744436, 29260090, 22967285) -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GLI2: BP4, BS1, BS2 -

not specified Benign:2
Aug 13, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 9;C4014479:Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 9 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
3.0
DANN
Benign
0.24
DEOGEN2
Benign
0.29
T;T
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.60
.;T
MetaRNN
Benign
0.0033
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.90
L;L
PhyloP100
-0.031
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.017
Sift
Benign
0.65
T;T
Sift4G
Benign
0.42
T;T
Polyphen
0.0010
B;B
Vest4
0.029
MPC
0.33
ClinPred
0.0016
T
GERP RS
1.0
Varity_R
0.067
gMVP
0.13
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114376238; hg19: chr2-121747433; COSMIC: COSV58044406; API